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DNA sequ~.n¢¢ polymorphisms in transthyr©tin (TTR) g~n¢~ were in~,¢stigated by single.strand conformation polymorphism (S$CP) analyiis of 
polymeras¢ chain reaction producm, The amplified DNA fraliments that encode ach ¢xon of the normal T'rR l~ne showed two bands, mpr¢sentinl~ 
the two complementary single strands of DNA. In cue patient with amyloid polynearopathy, thtexon 3 DNA thawed aunique, a~rrant mi~ation 
pattern. Direr sequencing analysis of the amplified ¢.xon 3 rev~lcd a single base change (G.to-T}, resulting in a nov~l amino acid subsUtation 
($¢r.50 ~ 11¢). We aim priest the SSCP patterns ['or tlv¢ known Japant'r¢ "['I'R variants, 
Familial amyloid polyneuropathy; Transthyrctin variant; Single-strand conformation polymorphism analysis; Japan~,¢ variant 
l, INTRODUCTION 
The human transthyretin (TTR) is a 55 kDa plasma 
protein composed of four identical subanit molecules, 
each consisting of 127 amino acids. Only a single amino 
acid substitution in the molecule can contribute to amy- 
laid fibril formation in familial amyloid polyneuropa- 
thy (FAP). Although FAP had been estimated to be 
very rare in Japan, using molecular cloning techniqu,s 
we have disclosed four different genotyp¢s in Japanese 
FAP [1-3]. Further screening and characterization of 
TTR variants may facilitate an understanding of the 
molecular basis for the amyloidosis associated with mu- 
tant TTR. 
We here report that single.strand conformation poly. 
morphisms (SSCP) provide novel genetic markers for 
variant TTR genes and identify a novel 'rTR mutant in 
a patient with amyloid polyneuropathy. 
2. MATERIALS AND METHODS 
2.1, DNA ~ampl¢~ 
Genomie nNAs were prepared from peripheral blood [eukocyt¢,~ 
from 50 hcahhy volunteers and '~0 patients without peripheral n~u- 
ropathy, The DNA -.,utopias obtained from a patient with TTR Met.30 
Abbrcvi.tious: TTR, transthyretini FAP, familial umyloid polyneu- 
ropathy; SSCP, single.strand conformation polymorphism(s); BCR, 
polymera.s¢ chain reaction; RFLP, r~trietion fragment length poly. 
morphism; Ago, allele.specific oligonucl¢otidc, 
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and tile four reposed patlenti [1-3], each having one of the following 
Gly.42. Arip50, Ar$,58 or Cys.114, were aim tested. 
2,2, P.tie.t 
A 56.year.old Japanese woman, living in Oita Frgfcetur¢, had a 
7-year.history of scn~P/disturbance and muscular atrophy in the 
lower limbs. The autonomic dydunction, mpcclally orlhostatic hypo- 
tension, limited hen= ambulation. Amyloid deposition was proven by 
a suml nerve biopsy, Ocnomic DNA waa prepangl from peripheral 
blood leukocyte. 
2,3. SSCP analysis of pot)'merase chain reaction ( PCRJ products 
Four pairs ofoligonucl~tid¢ primers dr'mr;bed previously [3] were 
used to amplify the. coding f,cquenc¢ in each oxen. General: DNA t '~ 
as) was amplified for 30 wcl~ (94'C for 30 s, 56"C for 45 ~ and "/2"C 
for 60 s) us;n8 the Gent Ampkit (Perkin Elmer Catut) as rccom. 
mended by the supplier except for the addition of [g.~3]4CI'P (0,35 
~I, !,000 Ci/mmol) in a final volume of 5/zl, Each produ¢~, was diluted 
10.fold with load;n8 dye (95% formamid~. 20 mM EDTA, 0.05~ 
Bromophenol b ue altd 0,05% xylen¢ c~anol), and heated at 90°C for 
10 rain, 2gl ofcmch ~-ampI¢ wa~ ¢lcctrophor©sgl on 6% non-denatur- 
ing polyacwlamid= 2,'Is ¢ontaining 45 mM Trig-borate (pH a.3), I mM 
EDTA and 5% glycerol at 26"C for 3 h at 2.000 V. The gel was dried 
and exposed to Kodak X-Omat AR film with intensifyi~B scrctn at 
M70¢C for 24, h, 
2,4. Dirert sequettcltt& annl.w'Lc 
The DNA fml~nents containing oxen 3 of the T'rR gone w~r¢ 
amplifi~l and isolat~ by asaros¢ sol ¢l~:trophor~is. The purified 
DNA was u~d as a template for the 2-step I~R amplification to 
obtain a single.stranded DNA suitable for direct sequence analysis. 
The first step was 20 cycles of symmetrical mplifi,mtion in 100/zl of 
reaction mixture, us;nil 10 n$ uf the purified DNA and 5 pmoi of 
primers of both ends, The second step was 18 ¢yol~ of asynlmetrie 
amplification (94~C for ~5 s, 570C for 15 s and ?2°C for 30 s) from 
20~ul oCth¢ first-step PCR product using 50 pmol of primer from either 
end, The amplified singl~-~trandcd DNA was dialyzed using thc Ccn- 
trie~n-30 microe~ncenttator (Ami~n) and was sequenced by modill. 
cation of the tc~hniqu~ of Niehol~ ct el, [4,], R~triclion fmgfnent 
len£th polymorphism (RFLP) analysis (see legend to Fig. 3) and allele- 
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Fill. i, SSCP analysis orcxon 2.3 and 4 ofTTR llen¢s. EIcctrophoresi,t wai performed on 6% non.dcmtturin= polyacrylamid¢ ll¢ls containinll 5,~ 
i]lyccrol at 26"C, The five known variants (Gly-42. Mct-3d, Ars-50. Arll.511 and Cys-114) showed ¢lcctrophoreti¢ mobility shirts, Exoj~ 3 DNA 
from the padcnt ( . )  prcicntcd an abcrr~.t SSCP pattern di~tinlluid~abl¢ from controls, ArB-SO and Arl~-51t, 
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Fig. 2. An  autoradio~ram ofa dir~t i~qu=ncin~ ttel for TTR ~xon 3 
from the' pati,'nt asinB an aiymmetric PCR product, Guanine and 
thymin= at th= sam= nu¢lcotid¢ position (indicated by arrow) showed 
the pr¢icnec or two ¢odons at position 50. AGT coding for Set and 
ATT codin~ for I1=, 
36 
~p¢¢i1"i¢ oli~onu¢I¢otid¢ (AS(I) analysis was done to ¢onfirin the de- 
re:ted mutation. 
'~, RESULTS AND DISCUSSION 
SSCP analysis of the normal homozygous samples 
presented only two bands, representing the two comple- 
mentary single strands of DNA.  The DNA fragments 
from the five variant q"rR genes showed various elec- 
trophoretic patterns (Fig. I). Tlz¢ hctcrozygous samples 
(TTR Oly-42 and Cys-ll4) presented two additional 
bands corresponding to the two complementary strands 
of the mutant allele. On the other hand, TTR IV[¢t-30, 
Arg-50 and Arg-5S had three distinct bands when only 
one strand of the mutant allele was expel;ted to have a 
novel conformation with a different electrophorcti¢ mo- 
bility, The other strand, posncssing the complementary 
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Fig. 3, RFLP analysis of the "l-rE ll¢,f~O I~n¢, Forward primer (3.FN: 
S'-AGACTTTCACACCTTATAGGAAATGCA.3 °) with tw~ ba~ 
substitutions (A, to.T and C.to.G: indicated by arrows), :tnd ~versc 
primer (3-R: 5 ' .AAAACAACCCrCGAAGGTCTGTATACI 'CAC.  
3') were s)'nthcsixed to amplify the two different :dlelic cson 3 fralP 
merits (IKb bp). The genomie DNAs from tho patient and a ¢.'mtrol 
were ;u'nplificd for 3(1 cycles (94'C for I rain, S4*C for I rain and 72"C 
for I mitt), The =~orn'=al a11¢1¢ h:td two primer.introduced base clgmg~, 
whilo the nluta~.t had :i third b'tsc chang<' tO.to-T: indicated by *), 
Only th¢ Iztttcr allelic scqu¢ne¢ could produce a new rcstrJclion site for 
Nsil. :rod thereby the mutant alfclic segment could be digcsled {t~lo two 
l'r;igm~:nts (15g and 2"/hp). The digested products wcrc elcctrophorcs. 
cd on :~ 3.7~ Nusieve agarosc ~,cl, The [~ticnt was hctcroz),gous lot' 
the/VsiI site. while ;I control had no sites in the TTR =else, 
The mechanism by which variant TTR molecules arc 
deposited is not fully understood. We cannot rule out 
the possibility that a mutation at phylogenctically con- 
scrve.d sites of the TI'R molecule is important for the 
amyloid formation. Met-30, Gly-42, Arg-47 and Arg-S8 
occurred at the conserved sites among human, rabbit, 
rat and mouse [6.7], but the other Arg-50. lle*S0 and 
Cys.114 occurred at the non..c.on=crvcd sites. All these 
mutations were located around the junction an=as con- 
heeling the loop and th~,8.pleatcd sheet [8]. It is spccu- 
luted that point mutations in the junction an=as may 
produce critical confonnntional changes of the mole- 
cule. thereby causing amyloid deposition. 
Among 17 TTR variants reported from a number or 
countries [1-3.9-13]. the six variants an= restricted 
within the Japanese race and only Met-30 is widely 
distributed, This fact shows the striking heterogeneity 
of Japanese FAP at the molecular level and suggests 
that it has u diverse origin with each mutation possibly 
originating from different ethic groups. 
I n summary. SSCP of the six variant TTR genes have 
been illustrated, and wc have r¢portcd a ~+c';: ~.utant 
gene, TTR lie-S0, in a patient with amyloid polyncu- 
ropathy, 
..Irkmm'ledxements," Dr  S, Ueno ~s  supported in part by a Ilrant 
from the Scnri Life ~icne= C~nter. 
base substitution, did not have a new conformati~on to 
cause a mobility shift, and continued to migrate wilh the 
corresponding strand of the normal allele, 
SSCP .'malysis of ¢xons 1, 2 and 4 from the p~tient 
with ,tmyloid polyncuropathy (see section 2) showed the 
same pattern as controls, but cxon 3 presented :in abet- 
nmt migration pattern, suggesting sequence alter-'ttions 
in the cxon (Fig. 1), Direct sequence analysis revealed 
both G and T at nuclcofidc position 3,2Sl [S]. This 
result indicated that the patient was heterozygotLs for 
the TTR gone. S¢r-50 and lie-S0 (Fig, .')). The sequence 
of the entire length of each cxon ~nd cxon-intron 
boundaries, as determined by the method escribed pre- 
viously [1,2], had the same base chang,, and there were 
no other sequence alterations. The base change was 
conftrmed by R, FLP analysis using a mismatch ;)rimer 
(Fi~, 3), The mutation was further confirmed by ASO 
hybridization analysis, The normal complementary 
ASO probe (5'-CCAGACTCAC_.TGGTn'TCC-3') and 
the mutant on~ with a C-to-A base ch.~gc atthe ~ndcr- 
lined position were synthesized, Amplified ¢xon 3 from 
the patient and 100 controls were tested as described 
previously [1-3], Exon 3 of the parle.: hybridized with 
both the normal and the mutant prot,.'s, whereas con- 
trois hybridized only witl~ the normal probe (data not 
shown), 
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